The invention relates to a system for controlling a cardiac support system comprising a control device, a cardiac support system and a method for controlling said system.
In modern cardiac support systems, also referred to as a VAD for “ventricular assist device” or a ventricular support system, a pump to support the heart function is usually implanted on or in the heart and controlled by a control device. In addition to or instead of a likewise implanted control device, a so-called extracorporeal control device can be provided, which is located outside the patient's body to enable external control.
From US 2005/0107658 A1, for example, a cardiac support system is known, which comprises both an implanted control device and an extracorporeal control device. The extracorporeal control device is wirelessly connected to the implanted control device and is used primarily for bidirectional data exchange.
Based on this, the underlying object of the invention is to further improve the known systems and methods, and in particular to enable simple and rapid information acquisition as well as coordinated control, to facilitate handling, to increase user friendliness and to ensure reliable and safe operation.
With this in mind, the invention relates to a system for controlling a cardiac support system comprising a first extracorporeal control device, wherein the first control device is or can be connected to the cardiac support system with a wire or a first coil for communication and/or energy transfer. The system further comprises a second extracorporeal control device which is wirelessly connected to the first control device and/or to the cardiac support system.
A cardiac support system is in particular to be understood to be a system to support the function of a heart of a human or an animal, also referred to as an artificial heart, a ventricular assist device (VAD) or a ventricular support system. The term “extracorporeal control device” generally refers to a control device for a cardiac support system that is not intended for implantation into a body of a human or an animal, but rather is intended and configured for use outside the body. For this purpose, the extracorporeal control device in particular comprises a display and/or an input device, in particular keys or buttons or a touch-sensitive surface. A wireless connection between two devices, or between a system and a device, is in particular to be understood to mean that the two devices, or the system and the device, are configured to communicate via a wireless bidirectional data connection, in particular via a radio link. A configuration or a setup of one of the control devices can be understood here and in the following to mean that the control device comprises correspondingly required hardware components, in particular a processor and communication interfaces, and is programmed accordingly, in particular the processor. The control device can be a commercially available control device for a cardiac support system, for example, which is set up, in particular programmed, according to the invention. In the context of the invention, a wire is in particular to be understood to be a wire referred to as a “driveline,” which is configured to connect the cardiac support system to the control device.
The system according to the invention has the advantage that the second extracorporeal control device provides an additional option for the user, in particular the patient or the physician, to access and gather information about the cardiac support system and also to control the cardiac support system, in particular a motor or a pump of the cardiac support system. In particular when the first extracorporeal control device is connected to the cardiac support system via the wire, i.e. the above-mentioned driveline, the not physically connected second extracorporeal control device advantageously enables a simple and rapid acquisition of information and coordinated control. Since the second control device does not have to be physically connected to any other device, it can advantageously also be handled and tucked away more discreetly. The second extracorporeal control device can furthermore be configured to be attached via a holder to a belt or other article of clothing of the patient for quick access. The flexible manageability via the second control device also advantageously allows the first extracorporeal control device to be worn as close as possible to or directly on the body, and thus reduces the distance to the implanted cardiac support system for the most reliable interaction possible. On the one hand, therefore, this advantageously increases safety and reliability, and with it also the patient's sense of security, and, on the other hand, it improves the overall comfort and user-friendliness. A control device that is not physically connected can be carried in easy reach more inconspicuously in public and is more inconspicuous to handle, so that the use of a cardiac support system is thus advantageously less conspicuous to third parties.
The second extracorporeal control device is preferably configured as a redundant unit to the first extracorporeal control device. In other words, the second extracorporeal control device is configured to take over the function of the first extracorporeal control device in the event of a failure or a malfunction of the first extracorporeal control device.
According to a particularly advantageous further development of the invention, the first control device and the second control device are structurally identical. This means in particular that the first control device and the second control device comprise the same hardware components and/or have the same structural design. The two control devices preferably also have the same exterior shape and the same exterior dimensions. This has the advantage that the first control device can easily be replaced by the second control device if necessary, for example in the event of a malfunction or a failure of the first control device as described above.
In a particularly advantageous further development of the invention, the first control device is configured as a server and the second control device is configured as a client. In other words, the two extracorporeal control devices form a network, in which the first extracorporeal control device assumes the role of the server and the second extracorporeal control device assumes the role of the client. This advantageously allows the client-server model, which has proven to be successful for networks, to be used.
In the event of an input to the first control device or to the second control device, the first control device and the second control device are preferably configured to cause the second control device or the first control device to accept the same input. If said input changes settings in the first or second control device, the same changes to the settings are then advantageously made in the second or first control device. The two control devices are thus advantageously in the same or in a synchronous state.
In a preferred further development of the invention the system comprises a first energy store for a transfer of energy via the first coil to the cardiac support system, wherein the first energy store is preferably, in particular detachably, connected to the first control device. An energy supply to the implanted cardiac support system can thus advantageously be controlled via the first extracorporeal control device. The system can preferably comprise a second energy store, which is preferably, in particular detachably, connected to the second control device. This has the advantage that the energy supply to the system as a whole is safeguarded even more.
In another advantageous configuration of the invention, the first control device and/or the second control device are configured to output an alarm signal when a minimum distance between the two control devices is exceeded. The control devices can be configured to estimate the current distance via the quality of the wireless radio links between the two control devices, for example, and compare it to the minimum distance. A strength or intensity of the signals received via the wireless connection, for example, can be used as a measure of the quality. For example, if the quality, in particular the signal strength or signal intensity, is less than a predefined minimum value, the alarm signal is triggered. The alarm signal can be emitted acoustically as a tone or tone sequence, for example, or optically via light-emitting elements of the control device or a display of the control devices. This has the advantage that the user or patient is reminded to carry both control devices.
The invention further relates to a cardiac support system comprising a system according to the invention.
The invention also relates to a method for controlling a cardiac support system, wherein the cardiac support system is controlled via a first extracorporeal control device and wherein the first control device or the cardiac support system is connected wirelessly to a second extracorporeal control device in order to control a cardiac support system. If the second control device is wirelessly connected to the first control device, the cardiac support system can be controlled by the second extracorporeal control device via the first extracorporeal control device.
With respect to the advantages of the cardiac support system according to the invention and the method according to the invention, reference is made to the corresponding advantages of the system according to the invention discussed above.
Design examples of the invention are shown schematically in the drawings and explained in more detail in the following description. The same reference signs are used for the elements shown in the various figures, which have a similar effect, whereby a repeated description of these elements is omitted.
The figures show:
In this design example, the two control devices 110, 120 are structurally identical and preferably have the same structural design, so that the second control device 120 can take over the function of the first control device if necessary and is thus provided as a redundant unit to the first extracorporeal control device. For this purpose in particular, the second control device 120 can also comprise a further energy source 161 to safeguard the energy supply of the cardiac support system.
Number | Date | Country | Kind |
---|---|---|---|
10 2018 218 770.3 | Nov 2018 | DE | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2019/079905 | 10/31/2019 | WO | 00 |